On the last day of its spring session, the U.S. Supreme Court ruled in a long-anticipated death penalty case, Glossip v Gross.
Though the case’s scope was narrow – only relevant to one drug used in a handful of state execution protocols – the oral arguments held in April unfolded with rare courtroom drama and revealed deep disagreement between the Justices about the death penalty in the United States.
The Court’s final ruling in favor of Oklahoma’s right to use the drug in question – midazolam – seemed to ignore the fact that the death penalty is falling into disuse around the country and that there is a growing consensus across the political spectrum that it is broken beyond repair. But those facts were not lost on the Court’s minority.
Source:: Equal Justice USA